Email
Print
The
Generalized Anxiety Disorder Market evolves the techniques of diagnosing, controlling and preventing the anxiety disorder. Generalized anxiety disorder is also known as GAD, which is characterized by excessive anxiety and worry about everyday life events with no apparent reason. Symptoms of anxiety disorder are muscle tension, headache, sweating and tiredness.
Also, rarely GAD occurs alone as it often accompanied by other anxiety disorder, substance abuse, anxiety and depression. Types of anxiety are segmented as Antidepressant, Benzodiazepines and Others (Buspirone). Number of factors are responsible to develop GAD which includes genetics, brain chemistry, and environmental factors such as trauma and stressful event, family background, or life experiences. The prevalence of anxiety symptoms in men is less as compared with women.
Increasing incidence rate due to more stressful life and sedentary lifestyle are the major factors that drives growth for the Generalized Anxiety Disorder Market. Increasing awareness about these kind of anxiety disorders and anxiety treatment is the growth driver of the market. Focusing on emerging countries such as China, Russia, India, Brazil and South Africa would create an opportunity for a market players.
However, poor diagnosis rate as there is no single diagnosis test is available to detect general anxiety disorder, affectivity of psychotherapy, and side effects of medications such as habit forming nature, dry mouth, and nausea are the key factors that restrains the Generalized Anxiety Disorder Market growth.
North America is leading the Generalized Anxiety Disorder Market with highest market share due to high R & D activities by pharmaceutical industry in this region. Europe is the second position due to higher patients complaining about stressful life style resulting into GAD, followed by Asia-Pacific. Asia-Pacific is expected to register the fastest growth during the forecast period due to changing life style lead to increasing stress, and growing facilities to detect anxiety disorders.
Also, rarely GAD occurs alone as it often accompanied by other anxiety disorder, substance abuse, anxiety and depression. Types of anxiety are segmented as Antidepressant, Benzodiazepines and Others (Buspirone). Number of factors are responsible to develop GAD which includes genetics, brain chemistry, and environmental factors such as trauma and stressful event, family background, or life experiences. The prevalence of anxiety symptoms in men is less as compared with women.
Increasing incidence rate due to more stressful life and sedentary lifestyle are the major factors that drives growth for the Generalized Anxiety Disorder Market. Increasing awareness about these kind of anxiety disorders and anxiety treatment is the growth driver of the market. Focusing on emerging countries such as China, Russia, India, Brazil and South Africa would create an opportunity for a market players.
However, poor diagnosis rate as there is no single diagnosis test is available to detect general anxiety disorder, affectivity of psychotherapy, and side effects of medications such as habit forming nature, dry mouth, and nausea are the key factors that restrains the Generalized Anxiety Disorder Market growth.
North America is leading the Generalized Anxiety Disorder Market with highest market share due to high R & D activities by pharmaceutical industry in this region. Europe is the second position due to higher patients complaining about stressful life style resulting into GAD, followed by Asia-Pacific. Asia-Pacific is expected to register the fastest growth during the forecast period due to changing life style lead to increasing stress, and growing facilities to detect anxiety disorders.
Browse Related Reports:
- Biological Safety Testing Market: By Products (Instruments, Kits & Reagents), By Test Type (Endotoxin Tests, Sterility Test, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Toxicity Tests and Stability Tests), By Application (Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy and Cellular Therapy) & By Region - Forecast (2017- 2022)
https://www.industryarc.com/Report/16699/biological-safety-testing-market.html
- Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region (Europe, North America, Others)-Forecast (2016-2021)
https://www.industryarc.com/Report/16271/substance-abuse-treatment-market.html
About IndustryARC:
IndustryARC
is a research and consulting firm that publishes more than 500 reports
annually in various industries, such as Agriculture, Automotive,
Automation & Instrumentation, Chemicals and Materials, Energy and
Power, Electronics, Food & Beverages, Information Technology, Life
sciences & Healthcare.
IndustryARC
primarily focuses on Cutting Edge Technologies and Newer Applications
of the Market. Our Custom Research Services are designed to provide
insights on the constant flux in the global demand-supply gap of
markets. Our strong analyst team enables us to meet the client research
needs at a very quick speed with a variety of options for your business.
We
look forward to support the client to be able to better address
customer needs; stay ahead in the market; become the top competitor and
get real-time recommendations on business strategies and deals. Contact
us to find out how we can help you today.
Contact Us:
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)